Kruit A - Search Results

1

Angiotensin II receptor type 1 1166 A/C and angiotensin converting enzyme I/D gene polymorphisms in a Dutch sarcoidosis cohort.

Kruit A, Ruven HJ, Grutters JC, van den Bosch JM. Kruit A, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):147-52. Sarcoidosis Vasc Diffuse Lung Dis. 2010. PMID: 21319597

2

Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients.

Kruit A, Ruven HJ, Grutters JC, van den Bosch JM. Kruit A, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct;22(3):195-203. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 16315782

3

The mucin-1 568 adenosine to guanine polymorphism influences serum Krebs von den Lungen-6 levels.

Janssen R, Kruit A, Grutters JC, Ruven HJ, Gerritsen WB, van den Bosch JM. Janssen R, et al. Among authors: kruit a. Am J Respir Cell Mol Biol. 2006 Apr;34(4):496-9. doi: 10.1165/rcmb.2005-0151OC. Epub 2005 Dec 15. Am J Respir Cell Mol Biol. 2006. PMID: 16357367

4

Chymase gene (CMA1) polymorphisms in Dutch and Japanese sarcoidosis patients.

Kruit A, Grutters JC, Ruven HJ, Sato H, Izumi T, Nagai S, Welsh KI, du Bois RM, van den Bosch JM. Kruit A, et al. Respiration. 2006;73(5):623-33. doi: 10.1159/000091190. Epub 2006 Jan 27. Respiration. 2006. PMID: 16446531

5

Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis.

Kruit A, Grutters JC, Ruven HJ, van Moorsel CH, Weiskirchen R, Mengsteab S, van den Bosch JM. Kruit A, et al. Chest. 2006 Jun;129(6):1584-91. doi: 10.1378/chest.129.6.1584. Chest. 2006. PMID: 16778279

6

ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis.

Kruit A, Grutters JC, Gerritsen WB, Kos S, Wodzig WK, van den Bosch JM, Ruven HJ. Kruit A, et al. Respir Med. 2007 Mar;101(3):510-5. doi: 10.1016/j.rmed.2006.06.025. Epub 2006 Aug 9. Respir Med. 2007. PMID: 16901684 Free article.

7

A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker.

Kruit A, Grutters JC, Ruven HJ, van Moorsel CC, van den Bosch JM. Kruit A, et al. Respir Med. 2007 Jul;101(7):1563-71. doi: 10.1016/j.rmed.2006.12.006. Epub 2007 Jan 22. Respir Med. 2007. PMID: 17236752 Free article.

8

MUC1 568 A/G genotype-dependent cancer antigen 15-3 levels in breast cancer patients.

Kruit A, Tilanus-Linthorst MM, Boonstra JG, van Schaik RH, Grutters JC, van den Bosch JM, Ruven HJ. Kruit A, et al. Clin Biochem. 2009 May;42(7-8):662-5. doi: 10.1016/j.clinbiochem.2008.11.020. Epub 2008 Dec 24. Clin Biochem. 2009. PMID: 19121298

9

CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases.

Kruit A, Gerritsen WB, Pot N, Grutters JC, van den Bosch JM, Ruven HJ. Kruit A, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):138-46. Sarcoidosis Vasc Diffuse Lung Dis. 2010. PMID: 21319596

10

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.

Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, Heron M, van den Bosch JM, Grutters JC. Korthagen NM, et al. Among authors: kruit a. Respir Med. 2011 Jan;105(1):106-13. doi: 10.1016/j.rmed.2010.09.012. Respir Med. 2011. PMID: 20888745 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters